A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study.

Xiong, An-Wen; Fang, Jue-Min; Ren, Sheng-Xiang; Li, Wei; Wang, Jing; Zhao, Yu; Chen, Guo-You; Xu, Qing; Zhou, Cai-Cun

Xiong, An-Wen; Fang, Jue-Min; Ren, Sheng-Xiang; Li, Wei; Wang, Jing; Zhao, Yu; Chen, Guo-You; Xu, Qing; Zhou, Cai-Cun.

Afiliação

Xiong AW; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Fang JM; Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University, Shanghai, China.
Ren SX; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Li W; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Wang J; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Zhao Y; Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University, Shanghai, China.
Chen GY; Shanghai Humantech Biotechnology Co., Ltd, Shanghai, China.
Xu Q; Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University, Shanghai, China.
Zhou CC; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

Front Oncol ; 11: 745699, 2021.

Article em En | MEDLINE | ID: mdl-34804932

Palavras-chave

EGF-CRM197; Solid tumors; clinical trial; immunotherapy; therapeutic cancer vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google